• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名86岁男性退伍军人的CD4+慢性淋巴细胞白血病:病例报告。

CD4+ chronic lymphocytic leukemia in an 86-year-old male veteran: A case report.

作者信息

Abdelrahim Sara, Thai Glory H, Burke Juanita, O'Brien Timothy, Ansari Mohammad Q, Zhao Chen, Sakr Hany

机构信息

Department of Pathology Louis Stokes Veterans Affairs Medical Center Cleveland Ohio USA.

School of Medicine Case Western Reserve University Cleveland Ohio USA.

出版信息

EJHaem. 2024 Jun 21;5(4):845-850. doi: 10.1002/jha2.958. eCollection 2024 Aug.

DOI:10.1002/jha2.958
PMID:39157606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11327761/
Abstract

CD4+ chronic lymphocytic leukemia (CLL) represents an extremely rare example of phenotypic aberrancy within CLL. We present a case of an 86-year-old male veteran with a history of multiple comorbidities who was incidentally diagnosed with CD4+ CLL during a routine peripheral blood workup. This case highlights the diagnostic challenges and characteristic features of CD4+ CLL, including flow cytometric analysis, molecular, and fluorescence in situ hybridization findings. The patient was classified as asymptomatic CLL Rai stage 0, warranting regular monitoring without a need for treatment intervention.

摘要

CD4+慢性淋巴细胞白血病(CLL)是CLL中一种极为罕见的表型异常情况。我们报告一例86岁男性退伍军人病例,该患者有多种合并症病史,在常规外周血检查中偶然被诊断为CD4+CLL。本病例突出了CD4+CLL的诊断挑战和特征,包括流式细胞术分析、分子及荧光原位杂交结果。该患者被分类为无症状CLL Rai 0期,只需定期监测,无需治疗干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c54b/11327761/aca1ff17fc40/JHA2-5-845-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c54b/11327761/6e8026047aaf/JHA2-5-845-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c54b/11327761/aca1ff17fc40/JHA2-5-845-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c54b/11327761/6e8026047aaf/JHA2-5-845-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c54b/11327761/aca1ff17fc40/JHA2-5-845-g001.jpg

相似文献

1
CD4+ chronic lymphocytic leukemia in an 86-year-old male veteran: A case report.一名86岁男性退伍军人的CD4+慢性淋巴细胞白血病:病例报告。
EJHaem. 2024 Jun 21;5(4):845-850. doi: 10.1002/jha2.958. eCollection 2024 Aug.
2
Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study.SARS-CoV-2 mRNA 疫苗接种在慢性淋巴细胞白血病患者中引发渐进性免疫功能障碍:一项前瞻性队列研究。
PLoS Med. 2023 Jun 29;20(6):e1004157. doi: 10.1371/journal.pmed.1004157. eCollection 2023 Jun.
3
Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia.苯达莫司汀单药治疗晚期难治性慢性淋巴细胞白血病。
J Cancer Res Clin Oncol. 2001 Jan;127(1):48-54. doi: 10.1007/s004320000180.
4
Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): a matching-adjusted indirect comparison (MAIC).泽布替尼与阿卡拉布替尼治疗复发或难治性慢性淋巴细胞白血病(R/R CLL)的疗效:匹配调整间接比较(MAIC)。
Ther Adv Med Oncol. 2025 Jul 8;17:17588359251340554. doi: 10.1177/17588359251340554. eCollection 2025.
5
Alemtuzumab for patients with chronic lymphocytic leukaemia.阿仑单抗用于慢性淋巴细胞白血病患者。
Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD008078. doi: 10.1002/14651858.CD008078.pub2.
6
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: focus on the very early period and Omicron era.慢性淋巴细胞白血病中新冠疫情的结果:聚焦极早期和奥密克戎时代。
Blood Adv. 2025 Jul 8;9(13):3170-3181. doi: 10.1182/bloodadvances.2024015260.
7
Chronic lymphocytic leukemia with associated renal invasion and light chain-restricted deposition membranous nephropathy: a case report and literature review.伴有肾脏浸润及轻链限制沉积性膜性肾病的慢性淋巴细胞白血病:一例报告及文献复习
Ultrastruct Pathol. 2025;49(4):377-383. doi: 10.1080/01913123.2025.2506742. Epub 2025 May 25.
8
[Establishment of a chronic lymphocytic leukemia mouse model via adoptive transfer of Eμ-TCL1 transgenic splenocytes].[通过Eμ-TCL1转基因脾细胞的过继转移建立慢性淋巴细胞白血病小鼠模型]
Zhonghua Xue Ye Xue Za Zhi. 2025 May 14;46(5):445-452. doi: 10.3760/cma.j.cn121090-20241120-00461.
9
Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia.利妥昔单抗、奥法木单抗及其他用于慢性淋巴细胞白血病的抗CD20单克隆抗体
Cochrane Database Syst Rev. 2012 Nov 14;11(11):CD008079. doi: 10.1002/14651858.CD008079.pub2.
10
Enterovesical fistula in chronic lymphocytic leukemia transforming to Richter syndrome: a case report and literature review.慢性淋巴细胞白血病转化为里氏综合征时的肠膀胱瘘:一例报告及文献综述
BMC Urol. 2025 Jul 3;25(1):150. doi: 10.1186/s12894-025-01830-7.

本文引用的文献

1
Leukemia-associated aberrant immunophenotype: A flow cytometry-based experience of 110 cases from a tertiary care center in Northern India.白血病相关异常免疫表型:基于流式细胞术对印度北部一家三级医疗中心110例病例的研究经验
J Cancer Res Ther. 2023 Jul-Sep;19(5):1335-1339. doi: 10.4103/jcrt.jcrt_809_21.
2
Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL.慢性淋巴细胞白血病中的免疫球蛋白基因序列分析:ERIC(慢性淋巴细胞白血病欧洲研究倡议)的 2022 年更新建议。
Leukemia. 2022 Aug;36(8):1961-1968. doi: 10.1038/s41375-022-01604-2. Epub 2022 May 25.
3
The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019.
204 个国家和地区 1990 年至 2019 年慢性淋巴细胞白血病的全球负担及归因风险因素:基于 2019 年全球疾病负担研究的分析。
Biomed Eng Online. 2022 Jan 11;21(1):4. doi: 10.1186/s12938-021-00973-6.
4
Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features.MYD88 突变慢性淋巴细胞白血病的临床病理特征:L265P 和非 L265P 突变与不同特征相关。
Blood Cancer J. 2020 Aug 26;10(8):86. doi: 10.1038/s41408-020-00351-w.
5
Genomic alterations in chronic lymphocytic leukemia and their correlation with clinico-hematological parameters and disease progression.慢性淋巴细胞白血病的基因组改变及其与临床血液学参数和疾病进展的相关性。
Blood Res. 2020 Sep 30;55(3):131-138. doi: 10.5045/br.2020.2020080.
6
Colorectal cancer statistics, 2020.2020 年结直肠癌统计数据。
CA Cancer J Clin. 2020 May;70(3):145-164. doi: 10.3322/caac.21601. Epub 2020 Mar 5.
7
The role of the genetic abnormalities, epigenetic and microRNA in the prognosis of chronic lymphocytic leukemia.基因异常、表观遗传学及微小RNA在慢性淋巴细胞白血病预后中的作用
Exp Oncol. 2018 Dec;40(4):261-267.
8
Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review.伴有 12 三体的慢性淋巴细胞白血病的形态学、免疫表型和遗传学特征:全面综述。
Haematologica. 2018 Jun;103(6):931-938. doi: 10.3324/haematol.2017.186684. Epub 2018 May 10.
9
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.iwCLL 指南:用于 CLL 的诊断、治疗指征、疗效评估和支持性管理。
Blood. 2018 Jun 21;131(25):2745-2760. doi: 10.1182/blood-2017-09-806398. Epub 2018 Mar 14.
10
Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.成熟 B 细胞肿瘤中最近鉴定的诊断、预后和预测分子生物标志物的临床实用性。
Mod Pathol. 2017 Oct;30(10):1338-1366. doi: 10.1038/modpathol.2017.58. Epub 2017 Jun 30.